This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

These factors could provide a scientific basis for consistency evaluations of the quality and efficacy of insulin biosimilars, study authors wrote. Factors that may affect the bioequivalence of test ...

Two long-acting insulin analogs have been developed for use as "basal" components of insulin treatment regimens: glargine and detemir. (Insulin glargine has US Food and Drug Administration [FDA] ...

New research suggests that a large portion of a diabetic's insulin dose is unlikely to work as expected. University of Copenhagen researchers have discovered that we have miscalculated insulin ...

Regular (R) insulin is a short-acting, injectable insulin used for the management of diabetes. It is typically taken before meals to prevent glucose from rising after a person eats. Regular insulin is ...

Cadenas, E., Kaji, H., Park, C. R., and Basmussen, H., J. Biol. Chem., 236, PC 63 (1961). Clauser, H., Volfin, P., Eboué-Bonis, D., and Chambaut, A. M ...

A Polish study comparing insulin pump technologies in children with type 1 diabetes found that advanced hybrid closed-loop ...

Diabetes requires an extremely precise form of daily treatment, whereby patients have to inject themselves with several doses of insulin every day, which are suited to their diet and physical activity ...

According to Harvard’s Dr. Elliott Proctor Joslin, at least 2,500,000 people in the U.S. have or will have diabetes before they die. According to Toronto’s Dr. Charles Herbert Best, co-discoverer of ...

Planning Phase 3 Oral Insulin study under revised protocol, new CRO agreement in place Oramed Pharmaceuticals (NASDAQ:ORMP) has pivoted its clinical R&D focus to prioritize studying ORMD 0801 for ...